:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Patricia M. Campbell, Marcelo Cantarovich, Azim Gangji, Isabelle Houde, Anthony M. Jevnikar, Felix‐Mauricio Monroy‐Cuadros, Peter W. Nickerson, Michel R. Pâquet, G. V. Ramesh Prasad, Lynne Senécal, Jean‐Luc Wolff, Jason J. Schwartz, David N. Rush
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Clinical Transplantation
Online Access:	https://onlinelibrary.wiley.com/doi/10.1111/ctr.70067
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Letter to the Editor: “Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients With Hypertension Combined Prediabetes”
by: Sabika Ayesha, et al.
Published: (2025)

A Letter to the Editor on “Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients with Hypertension Combined Prediabetes”
by: Ghaniya Khan
Published: (2025)

Role of Angiotensin Receptor Blockers on Cardiovascular Protection in Marfan Syndrome: A Literature Review
by: Hashim Mohamed Siraj, et al.
Published: (2025)

4C:ARA21 | Dose–Response Association of Angiotensin Receptor Blocker Exposure With Incident Dementia in Autoimmune Rheumatic Diseases: A Nationwide Cohort Study in Taiwan
Published: (2026)

Exploring Angiotensin II Receptor Blockers as a potential protective therapeutic for the Preclinical Stages of Alzheimer's Disease
by: Julia L Waszak, et al.
Published: (2025)

High‐Throughput Screening for Prescribing Cascades Among Real‐World Angiotensin‐ II Receptor Blockers ( ARBs ) Initiators
by: Asinamai M. Ndai, et al.
Published: (2025)

Novel Potential Genotoxic Impurity Identification and Quantification by Using Quality by Design Approach in Angiotensin II Receptor Blocker
by: Yerramreddy Srilatha, et al.
Published: (2025)

Utilization and Dose Optimization of Angiotensin‐Converting Enzyme Inhibitors in Heart Failure Patients With Reduced Ejection Fraction: A Cross Sectional Study on Implications for Guideline‐Targeted Therapy
by: Martin Kampamba, et al.
Published: (2025)

Management of a Patient With Polypharmacy Toxicity (Calcium Channel Blocker, Angiotensin Converting Enzyme Inhibitor and Tricyclic Antidepressant) in Intensive Care Settings: A Case Report
by: Sami Ur Rehman, et al.
Published: (2026)

Association of Angiotensin-Converting Enzyme Genotype, Insertion/Deletion Polymorphism and Saphenous Vein Graft Atherosclerosis in Iranian Patients
by: Neda Zeinali
Published: (2015)

Impact of Angiotensin‐Converting Enzyme Inhibitor on Coronary Artery Calcification Evaluated by Intravascular Ultrasound: A Retrospective Cohort Study
by: Daisuke Kanda, et al.
Published: (2025)

Analytical Interference in Chemiluminescence Assay–Measured Angiotensin I, Angiotensin II, Aldosterone, and Renin
by: Xiaohua Xu, et al.
Published: (2024)

Angiotensin Receptor–Neprilysin Inhibitor in Heart Failure Patients With Renal Dysfunction
by: Xiaogang Zhu, et al.
Published: (2024)

Rationale and Design of a Randomized, Open‐Label, Parallel‐Group Study of Esaxerenone Versus Angiotensin Receptor Blockers in Older Patients With Uncontrolled Hypertension on Calcium Channel Blocker Monotherapy (ESCORT‐HT)
by: Kazuomi Kario, et al.
Published: (2024)

A Retrospective Analysis of Human Angiotensin II Receptor Blockers (ARB) Pharmacokinetics, Dosages and C max Values for the Experimental Modelling of Pleiotropic and Supratherapeutic Activities
by: Alexandria Evans, et al.
Published: (2026)

Lower Risk of Alzheimer’s Disease and Related Dementias associated with Angiotensin Receptor II Blockers (ARBs) treatment for individuals with Hypertension in High‐volume Claims Data
by: Sori Kim Lundin, et al.
Published: (2024)

Tenerriside A, a Glycoside Variant From Sargassum tenerrimum , Exhibits Potent Angiotensin‐Converting Enzyme (ACE) Inhibitory Activity
by: Chaithanya Bose, et al.
Published: (2026)

Predictors of Discontinuation of Angiotensin Converting Enzyme Inhibitors Use Among Medicare Beneficiaries Using Sodium‐Glucose Cotransporter 2 Inhibitors
by: Hongjie Qian, et al.
Published: (2026)

Selection for Postponed Senescence in Drosophila melanogaster Reveals Distinct Metabolic Aging Trajectories Modifiable by the Angiotensin‐Converting Enzyme Inhibitor Lisinopril
by: Denise Vecchié, et al.
Published: (2026)

Increased Frequency of Angiotensin‐Converting Enzyme D Allele in Asian Patients With Chronic Obstructive Pulmonary Disease: An Updated Meta‐Analysis
by: Xiaozheng Wu, et al.
Published: (2024)

Angiotensin 1–7 Modulates the Dynamics and Activation of the Proto‐Oncogene Mas Receptor
by: Ekrem Yasar, et al.
Published: (2026)

Calcium Channel Blocker Versus Renin–Angiotensin System Inhibitor in Risk of Kidney Cancer Among Patients With Hypertension: A Propensity Score‐Matched Cohort Study
by: Minji Jung, et al.
Published: (2024)

Angiotensin‐Converting Enzyme 2 (G8790A) Gene Polymorphism as a Risk Factor for COVID‐19 in Egyptian Children and Adolescents
by: Ahmed A. A. Ibraheem, et al.
Published: (2025)

Renal and Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease Receiving Varying Doses of Renin-Angiotensin System Blockade
by: Demirelli, Bülent
Published: (2025)

Managing Delayed or Missed Doses of Prolonged‐Release Tacrolimus in Transplant Recipients: Implications for Drug Exposure and Recovery Strategies
by: S. Arraki Zava, et al.
Published: (2025)

Angiotensin (1–7) Improves Pancreatic Islet Function via Upregulating PDX‐1 and GCK: A Dose‐Dependent Study in Mice
by: Ziwei Lin, et al.
Published: (2024)

Renin‐Angiotensin‐Aldosterone System (RAAS) in Pig‐to‐Baboon Kidney Xenotransplantation—Relevance to Clinical Pig Kidney Xenotransplantation
by: Maho Terashita, et al.
Published: (2026)

Identification of the Heptapeptide PR7 and Octapeptide SF8 With Potent Antioxidative and Angiotensin Converting Enzyme Inhibitory Activity From the Fermented Dairy By‐Product “Buttermilk”
by: Osama Magouz, et al.
Published: (2024)

A Phase 1C, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DM199 Administered Intravenously with a Polyvinyl Chloride Bag in Adult Healthy Subjects and Adults Recently Taking Angiotensin‐Converting Enzyme Inhibitors
by: Michael Giuffre, et al.
Published: (2025)

Revealing Novel Angiotensin‐Converting Enzyme (ACE)‐Inhibitory Peptides From Mackerel Hydrolysates and Potential Antihypertensive Mechanism Using Virtual Screening and Network Pharmacology Analysis
by: Hui Zhang, et al.
Published: (2025)

Retracted: Biologically Synthesized Peptides Show Remarkable Inhibition Activity against Angiotensin-Converting Enzyme: A Promising Approach for Peptide Development against Autoimmune Diseases
by: BioMed Research International
Published: (2024)

Correction to “Controlled Hemorrhage Sensitizes Angiotensin II‐Elicited Hypertension Through Activation of the Brain Renin‐Angiotensin System Independently of Endoplasmic Reticulum Stress”
Published: (2026)

The Antioxidant Effects of Trypsin-Hydrolysate Derived from Abalone Viscera and Fishery By-Products, and the Angiotensin-I Converting Enzyme (ACE) Inhibitory Activity of Its Purified Bioactive Peptides.
by: Heo, Jun-Ho, et al.
Published: (2024)

ACE2 Mediated Cardiac Fibrosis Alleviation Through Angiotensin‐(1‐7)/Mas Axis Regulation of the Renin‐Angiotensin System/Rac Signaling Pathway
by: Lili Zou, et al.
Published: (2026)

Role of Angiotensin II in Venezuelan Equine Encephalitis: Narrative Review
by: Adriana Pedreañez, et al.
Published: (2025)

Sex‐Dependent Effects of Angiotensin II and Calcineurin in the Vasculature of Mice
by: Alexander Nolze, et al.
Published: (2026)

Angiotensin II Promotes the Phenotypic Transition of c‐Kit + Cardiac Interstitial Cells to Myofibroblasts Through Collagen Receptor Discoidin Domain Receptor 2
by: Indraja Devidasan, et al.
Published: (2026)

Genotype‐Guided Model for Prediction of Tacrolimus Initial Dosing After Lung Transplantation
by: Wenwen Du, et al.
Published: (2024)

Comment on “Model Informed Precision Dosing of Tacrolimus in Children Following Heart Transplant”
by: Princy Kashyap, et al.
Published: (2026)

Production of Angiotensin-I-Converting-Enzyme-Inhibitory Peptides in Fermented Milks Started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. / M. Gobbetti
by: Gobbetti, M
Published: (2000)